IDdriven, Inc. Stresses Role Management and Attestation Critical to Achieving Security
Aug 17, 2017 12:00 pm UTC| Business
SACRAMENTO, Calif., Aug. 17, 2017 -- IDdriven, Inc., (OTCQB:IDDR), an innovative provider of premises and cloud-based Identity and Access Management ("IAM") solutions, today stated the importance Role Management and...
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
Aug 17, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., Aug. 17, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced it has entered into a definitive securities purchase agreement with new and existing...
Ooma Expands Its Smart Communications Platform to Small Businesses of Any Size
Aug 17, 2017 12:00 pm UTC| Business
PALO ALTO, Calif., Aug. 17, 2017 -- Ooma, Inc. (NYSE:OOMA), a smart communications platform for business and consumers, today announced capabilities to serve the needs of small businesses from self-employed to those...
North State Reports Second Quarter 2017 Results
Aug 17, 2017 12:00 pm UTC| Business
HIGH POINT, N.C., Aug. 17, 2017 -- North State, a leading fiber optic network, cloud and IT services provider, announced today its financial results for the second quarter and six months ended June 30, 2017. Summary...
Aug 17, 2017 12:00 pm UTC| Business
DALLAS, Aug. 17, 2017 -- RMG Networks Holding Corporation (NASDAQ:RMGN), or RMG, a global leader in technology-driven visual communications, announced a $500,000 order with one of the largest banks in the world to...
HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Maryland
Aug 17, 2017 12:00 pm UTC| Business
TAMPA, Fla., Aug. 17, 2017 -- HCI Group, Inc. (NYSE:HCI) announced today that its wholly-owned insurance subsidiary, Homeowners Choice Property Casualty Insurance Company, Inc., has received regulatory approval to...
BeyondSpring to Present at the 2017 Southern California Investor Conference
Aug 17, 2017 12:00 pm UTC| Business
NEW YORK , Aug. 17, 2017 -- BeyondSpring Inc. (NASDAQ Capital Markets:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology cancer therapies, announced today that...